Review of Drug Resistance and Pathogenic Microorganisms

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/60

flashcard set

Earn XP

Description and Tags

This set of flashcards focuses on key vocabulary and concepts related to drug-resistant pathogens, particularly focusing on Pseudomonas aeruginosa and Candida auris, their implications in healthcare settings and related epidemiological factors.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

61 Terms

1
New cards

Pseudomonas aeruginosa

A gram-negative rod-shaped bacterium that is an opportunistic pathogen and has a high intrinsic resistance to many antibiotics.

2
New cards

Candida auris

An emerging multidrug-resistant yeast that can cause severe infections and spreads easily among hospitalized patients.

3
New cards

Drug resistance

The reduction in effectiveness of a medication such as an antibiotic in treating an infection.

4
New cards

Carbapenem-resistant Enterobacteriaceae (CRE)

A group of hard-to-treat infections caused by bacteria that have become resistant to a class of antibiotics known as carbapenems.

5
New cards

Vancomycin-resistant Enterococci (VRE)

Enterococci bacteria that have developed resistance to vancomycin, an antibiotic used to treat severe infections.

6
New cards

Methicillin-resistant Staphylococcus aureus (MRSA)

A type of staph bacteria that is resistant to many antibiotics, making it difficult to treat.

7
New cards

Epidemiology

The study of how diseases affect the health and illness of populations.

8
New cards

Biofilm

An assemblage of surface-associated microbial cells enclosed in a protective matrix.

9
New cards

Quorum Sensing

The chemical communication system used by bacteria to coordinate behavior based on population density.

10
New cards

Colony phenotype switching

The ability of bacteria or fungi to alter their physical characteristics in response to environmental changes.

11
New cards

Filamentation

The process by which yeast cells grow in a filamentous form, often associated with increased virulence.

12
New cards

Nonsocomial infections

Infections acquired in healthcare facilities that may be resistant to standard treatments.

13
New cards

Thermotolerance

The ability of an organism to grow at elevated temperatures compared to its counterparts.

14
New cards

Osmotolerance

The ability to survive in environments with high concentrations of salt.

15
New cards

Extended-spectrum beta-lactamase (ESBL)

Enzymes produced by some bacteria that can inactivate a wide range of beta-lactam antibiotics.

16
New cards

Antifungal resistance

The ability of fungi to withstand the effects of antifungal medications.

17
New cards

Morbidity

The condition of being diseased or having an illness.

18
New cards

Mortality

The state of being subject to death; often used in the context of disease.

19
New cards

Antimicrobial stewardship

Efforts to optimize the use of antimicrobial medications to combat resistance.

20
New cards

Infection control breaches

Failures to follow protocols designed to prevent the spread of infections.

21
New cards

Healthcare-associated infections (HAIs)

Infections patients get while receiving treatment for medical or surgical conditions.

22
New cards

Clinical isolate

A pathogen isolated from a clinical specimen, used for testing and further study.

23
New cards

Skin colonization

The presence of bacteria or fungi on the skin surface without causing infection.

24
New cards

Virulence factor

Any characteristic of a microbe that enhances its ability to cause disease.

25
New cards

Cystic Fibrosis (CF)

A genetic disorder affecting the lungs and digestive system, leading to thick mucus production.

26
New cards

Chronic infection

An infection that persists over a long period, often difficult to eradicate.

27
New cards

Healthcare workers

Individuals who provide health care services and may play a role in infection transmission.

28
New cards

Secondary metabolites

Organic compounds produced by an organism that are not directly involved in normal growth, development, or reproduction.

29
New cards

Intravenous catheter

A tube placed into a vein to administer fluids, medications, or nutrition.

30
New cards

High-risk populations

Groups of individuals more likely to acquire infections due to specific risk factors.

31
New cards

Invasive procedures

Medical interventions that involve entering the body, often increasing infection risk.

32
New cards

Antimicrobial agent

A substance that kills or inhibits the growth of microorganisms.

33
New cards

Resistance mechanisms

Various strategies used by microbes to evade destruction by antimicrobial substances.

34
New cards

Cross-resistance

The phenomenon where resistance to one antimicrobial agent confers resistance to another.

35
New cards

Traveler data analysis

Examination of data related to individuals traveling between regions to track infection spread.

36
New cards

Mucus accumulation

The buildup of thick mucus in organs, commonly seen in cystic fibrosis.

37
New cards

Acidic filtration

A filtration process that removes contaminants via an acidic solution.

38
New cards

Environmental survival

The ability of a microorganism to persist outside a host.

39
New cards

Pathogenesis

The process by which an infectious agent causes disease.

40
New cards

Regulatory genes

Genes responsible for controlling the expression of other genes.

41
New cards

Secondary infection

An infection that occurs during or following another infection.

42
New cards

Fungal infections,

Infections caused by fungi, often difficult to treat due to resistance.

43
New cards

Linezolid

An antibiotic used to treat infections caused by resistant Gram-positive bacteria.

44
New cards

Culture and sensitivity testing

Laboratory tests to determine the type of bacteria and its susceptibility to antibiotics.

45
New cards

Pseudomonas aeruginosa outbreak

An occurrence of a higher-than-normal number of infections caused by P. aeruginosa in a specific area.

46
New cards

Outbreak investigation

The process of identifying and controlling a disease outbreak.

47
New cards

ICU patients

Patients being treated in an intensive care unit, often at higher risk of infections.

48
New cards

Surgical site infections

Infections that occur after surgery in the part of the body where the surgery took place.

49
New cards

Contamination risk

The likelihood of a harmful agent coming into contact with a patient or environment.

50
New cards

Intravaginal infections

Infections occurring within the vaginal canal often due to fungal or bacterial pathogens.

51
New cards

Antifungal susceptibility testing

Assessing the effectiveness of antifungals against fungal pathogens.

52
New cards

Pneumonia

An infection that inflames the air sacs in one or both lungs, causing cough and difficulty breathing.

53
New cards

Antimicrobial resistance (AMR)

The resistance of a microorganism to an antimicrobial drug that was originally effective for treatment.

54
New cards

Fecal transplants

The process of transplanting stool from a healthy donor into a patient to restore healthy gut microbiota.

55
New cards

Public health concern

An issue that affects the health of the public and requires collective action.

56
New cards

Precautionary measures

Steps taken to prevent infection spread in healthcare settings.

57
New cards

Risk stratification

The process of determining the risk levels of patients to tailor prevention strategies.

58
New cards

Yeast infection

An infection caused by an overgrowth of yeast, often Candida species.

59
New cards

Drug-resistant Candida

Candida species that have developed resistance to antifungal medications.

60
New cards

Pharmacological treatment

Use of medication in treating diseases or conditions.

61
New cards

Community-associated infections

Infections acquired outside of healthcare settings.